COAGULATION-FACTOR ASSAY ABNORMALITIES IN 370 PATIENTS WITH BLOCKING INHIBITORS OF THE LUPUS TYPE (LUPUS ANTICOAGULANTS)

被引：0
|
作者：
BONTEMPO, FA
LEWIS, JH
机构：
[1] CENT BLOOD BANK PITTSBURGH,PITTSBURGH,PA
[2] UNIV PITTSBURGH,SCH MED,DEPT HEMATOL,PITTSBURGH,PA 15261
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1221 / 1221
页数：1
相关论文
共 50 条
  • [21] Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient
    Herbers, A. H. E.
    Verbruggen, B.
    Van De Veerdonk, F.
    Van Kraaij, M.
    Blijlevens, N. M. A.
    Novakova, I. R. O.
    HAEMOPHILIA, 2009, 15 (05) : 1164 - 1166
  • [22] Elevated Level of Plasma Coagulation Factor XIII Correlates To Atherosclerosis In Lupus Patients
    Matsuura, I.
    Lourenco, E.
    Grossman, J.
    Skaggs, B.
    Ichinose, A.
    McMahon, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S44 - S44
  • [23] CORRECTION OF CLOTTING FACTOR DEFICIENCIES IN PLASMA FROM PATIENTS WITH LUPUS-LIKE ANTICOAGULANTS
    CLYNE, LP
    HONIG, CL
    DAINIAK, N
    THROMBOSIS AND HAEMOSTASIS, 1984, 51 (03) : 317 - 320
  • [24] Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II
    Simmelink, MJA
    Fernández, JA
    Derksen, RHWM
    Griffin, JH
    de Groot, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 676 - 684
  • [25] Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I
    Barone, R
    Giuffrida, G
    Musso, R
    Carpinteri, G
    Fiumara, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (04) : 387 - 390
  • [26] Improved assessment of coagulation factor activities in the presence of strong lupus anticoagulants achieved by immunoglobulin depletion of patient plasma.
    Adem, Patricia V.
    Wilcox, Rebecca L.
    Miller, Jonathan L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (03) : 471 - 472
  • [27] REMOVAL OF A BLOCKING FACTOR FROM SERA OF PATIENTS WITH SYSTEMATIC LUPUS-ERYTHEMATOSUS WITH LEVAMISOLE
    ROSLING, AE
    RHODES, EL
    WATSON, B
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1978, 3 (01) : 39 - 42
  • [28] Nuclear factor (NF) kB abnormalities in lymphocytes from patients with systemic lupus erythematosus
    Wong, HK
    Dennis, G
    Kammer, GM
    Tsokos, GC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 549 - 549
  • [29] Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors
    Kumano, Osamu
    Amiral, Jean
    Dunois, Claire
    Peyrafitte, Marie
    Moore, Gary W.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 771 - 778
  • [30] Thrombin generation assay: Use in monitoring treatment of patients with coagulation factor inhibitors.
    McCormick, AN
    Turecek, PL
    Varadi, K
    Savidge, GF
    BLOOD, 2004, 104 (11) : 843A - 843A
12345